Event
Opentrons Completes $40 Million Series E Financing
1 reports · 1 sources
Lab automation company Opentrons Labworks announced the completion of a $40 million Series E financing round, led by healthcare investor Avego, with participation from BroadOak Capital Partners. The company said the funds will be used to expand its robotics, software, and data infrastructure, invest in AI-driven experiment execution, and expand into new markets and regions, in order to advance its "autonomous science" business, that is, enabling AI and robotic systems to collaboratively design and execute experiments and learn from the results. Opentrons said it has deployed more than 11,000 robots in over 80 countries, covering 90% of the world's top 20 pharmaceutical companies.
Report timeline
- Opentrons raises $40 million Series E to expand AI lab automation
Laboratory automation company Opentrons Labworks announced the completion of a $40 million Series E funding round led by Avego, with participation from BroadOak Capital Partners. The funds will be used to expand its robotics, software, and data infrastructure, advance AI-driven experiment execution, and expand into new markets and regions. The company says it has deployed more than 11,000 robots in over 80 countries, covering 90% of the world's top 20 pharmaceutical companies.
Robotics & Automation News ·